SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (2583)7/25/2000 11:09:13 AM
From: DanZ  Read Replies (1) of 5582
 
<They announced this "deal" over six months ago and have yet to finalize an agreement. If there were no objections to this marriage, the deal would have been done by now and the product would be in production.>

Huh? This is just one more example of your unresearched off-the-cuff cow manure comments.

Gum Tech International and Swedish Match Finalize Joint Venture Agreement

PHOENIX, July 6 /PRNewswire/ -- Gum Tech International, Inc. (Nasdaq: GUMM - news) and Swedish Match AB (Nasdaq: SWMAY; Stockholm: SWMA) today announced the execution of definitive agreements for a Joint Venture to develop, manufacture, market and distribute non-tobacco nicotine products worldwide.

biz.yahoo.com

Gum Tech said in a press release that they expect to begin production of nicotine gum by the first quarter of 2001. Notice that the joint venture is for non-tobacco nicotine products worldwide. This includes products such as patches, lozenges, nasal gels, and all other non-tobacco nicotine products. Neither Swedish Match, nor Gum Tech, can market any non-tobacco nicotine products anywhere in the world outside the joint venture. Not bad for a POS company, huh?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext